Memantine and Leukocytosis - a phase IV clinical study of FDA data

Summary:

Leukocytosis is reported as a side effect among people who take Memantine (memantine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Declomycin, and have Pain.

The phase IV clinical study analyzes which people have Leukocytosis when taking Memantine. It is created by eHealthMe based on reports of 10,128 people who have side effects when taking Memantine from the FDA, and is updated regularly.

What is Memantine?

Memantine has active ingredients of memantine. It is often used in alzheimer's disease. eHealthMe is studying from 10,266 Memantine users. Check the latest studies of Memantine.

What is Leukocytosis?

Leukocytosis (increased white blood cells) is found to be associated with 1,334 drugs and 1,779 conditions by eHealthMe. Check the latest studies of Leukocytosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

10,128 people reported to have side effects when taking Memantine.
Among them, 13 people (0.13%) have Leukocytosis.

Among these 13 people:

How long have people been on Memantine when they have Leukocytosis? *

What is the gender of people who have Leukocytosis when taking Memantine? *

female: 75 %
male: 25 %

What is the age of people who have Leukocytosis when taking Memantine? *

What are other drugs people take besides Memantine? *

What are other side effects people have besides Leukocytosis? *

Dehydration (dryness resulting from the removal of water): 6 people, 46.15%
Fever: 5 people, 38.46%
Drowsiness: 5 people, 38.46%
Confusional State: 5 people, 38.46%
High Blood Pressure: 5 people, 38.46%
Blood Urea Increased: 5 people, 38.46%
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 4 people, 30.77%
Congestive Cardiomyopathy (weakening of heart muscle): 4 people, 30.77%
Left Ventricular Dysfunction: 4 people, 30.77%
Hypotension (abnormally low blood pressure): 4 people, 30.77%

What are the existing conditions these people have? *

Pain: 5 people, 38.46%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 4 people, 30.77%
High Blood Pressure: 3 people, 23.08%
Nausea (feeling of having an urge to vomit): 3 people, 23.08%
Constipation: 3 people, 23.08%
Memory Loss: 3 people, 23.08%
Depression: 3 people, 23.08%
Diabetes: 3 people, 23.08%
Inappropriate Antidiuretic Hormone Secretion: 3 people, 23.08%
High Blood Cholesterol: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Memantine and have Leukocytosis?

- Check whether Leukocytosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Memantine:

Memantine (10,266 reports)

Leukocytosis treatments and more:

Leukocytosis (22,918 reports)

Browse all side effects of Memantine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Leukocytosis:

Leukocytosis (1,334 drugs)

Browse all the conditions that are associated with Leukocytosis:

Leukocytosis (1,779 conditions)

Related publications that referenced our studies

Khan A, Yasin Z, "Hyperleukocytosis Caused By Neulasta Complicated By Leukostasis Versus Asymptomatic Uncomplicated Hyperleukocytosis In AML. Two Cases and When To Leukapherese.", Am Soc Hematology, 2017 Jan .
Khan A, Yasin Z, "Hyperleukocytosis Caused By Neulasta Complicated By Leukostasis Versus Asymptomatic Uncomplicated Hyperleukocytosis In AML. Two Cases and When To Leukapherese.", Am Soc Hematology, 2017 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on memantine (the active ingredients of Memantine) and Memantine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.